Bli medlem
Bli medlem

Du är här

2016-10-21

Xvivo Perfusion: Conference call on Interim Report

Invitation to attend XVIVO Perfusion's conference call regarding the
presentation of the Interim Report January - September 2016. The
presentation will be held in English.

Time: Thursday, October 27, 2016 at 3.00 p.m. CET

Registration can preferably be done in advance under the following
link:

https://engage.vevent.com/rt/xvivoperfusion/index.jsp?seid=71
or shortly before time of the conference starts on:
Sweden dial in number: +46 (0) 8-506 921 80
International dial in number: +44 (0) 2071 928 000
Conference name: XVIVO Perfusion, conference ID: 94108581

Participants from XVIVO Perfusion:
Magnus Nilsson, CEO
Christoffer Rosenblad, CFO

The press release for XVIVO Perfusion's Interim Report January -
September 2016 will be released before the conference call October
27, 2016.

Before the conference call, slides will be available at the company
web page, www.xvivoperfusion.com/corporate/.

October 21, 2016
Gothenburg
XVIVO Perfusion AB (publ)

For further information please contact:
Christoffer Rosenblad, CFO, +1 720 616 2101,
christoffer.rosenblad@xvivoperfusion.com

Magnus Nilsson, CEO, +46 31-788 21 50,
magnus.nilsson@xvivoperfusion.com
(christoffer.rosenblad@xvivoperfusion.com)

This is a translation of the Swedish version of the press release.
When in doubt, the Swedish wording prevails.

______________________________________________________________________________________________________________________

XVIVO Perfusion AB is a medical technology company which develops
solutions and systems for assessing and preserving organs outside the
body and for selecting usable organs and maintaining them in optimal
condition pending transplantation.

The company is headquartered in Gothenburg, Sweden, and has one office
in Lund, Sweden and one office in Denver, the USA. The XVIVO share is
listed on NASDAQ First North premier and has the ticker symbol XVIVO.
More information can be found on the website www.xvivoperfusion.com.
The Certified Adviser is Redeye, www.redeye.se.

______________________________________________________________________________________________________________________

XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate
identity number 556561-0424.

Tel: 46 31 788 21 50. Fax: 46 31 788 21 69.
E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com
-----------------------------------------------------------
http://news.cision.com/xvivo-perfusion/r/conference-call-on-interim-repo...
http://mb.cision.com/Main/4567/2105661/578034.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.